A case of mycosis fungoides successfully treated with combination of bexarotene and mogamulizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A case of mycosis fungoides successfully treated with combination of bexarotene and mogamulizumab

Published:2021-01-27 Issue:2 Volume:34 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Hisamoto Teruyoshi¹,Suga Hiraku¹^ORCID,Kawana Yuki¹,Oka Tomonori¹,Miyagaki Tomomitsu²^ORCID,Sugaya Makoto³,Sato Shinichi¹

Affiliation:

1. Department of Dermatology University of Tokyo Graduate School of Medicine Tokyo Japan

2. Departments of Dermatology St. Marianna University School of Medicine Kawasaki Japan

3. Department of Dermatology International University of Health and Welfare Chiba Japan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14805

Reference7 articles.

1. Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results

2. Results of a Phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma

3. Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma

4. Results from a Phase I/II Open-Label, Dose-Finding Study of Pralatrexate and Oral Bexarotene in Patients with Relapsed/Refractory Cutaneous T-cell Lymphoma

5. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments;Antibodies;2024-04-22

2. Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review;International Journal of Molecular Sciences;2024-02-12

3. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023;European Journal of Cancer;2023-12

4. Cutaneous T cell lymphoma treated with mogamulizumab monotherapy and mogamulizumab plus etoposide combined therapy: A real‐world case series;Dermatologic Therapy;2022-10

5. CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver;European Journal of Immunology;2021-05-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3